Icon

NOROXIN (nda019384)- (400MG)

NORFLOXACIN MERCK
400MG
No No
2005-Jan-22 Expired
None None
None No
NOROXIN is indicated for the treatment of adults with the following infections caused by susceptible strains of the designated microorganisms: Uncomplicated urinary tract - infections (including cystitis) due to Enterococcus faecalis, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Staphylococcus epidermidis, Staphylococcus saprophyticus, Citrobacter freundii, Enterobacter aerogenes, Enterobacter cloacae, Proteus vulgaris, Staphylococcus aureus, or Streptococcus agalactiae. Complicated urinary tract infections due to Enterococcus faecalis, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, or Serratia marcescens. Sexually transmitted diseases - Uncomplicated urethral and cervical gonorrhea due to Neisseria gonorrhoeae. Prostatitis - due to Escherichia coli.
0 0 0
Total Other Developers None
Drugs with Suitability No
400MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.